Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)

Lin, Jialing, Pearson, Sallie-Anne, Greenfield, Jerry R. · European Journal of Clinical Pharmacology · 2023